Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

February 3, 2010

New Drug Fights HIV and Many Other Viruses

Researchers found a new antiviral drug that appears to effectively target not only HIV, but also Ebola, influenza and Rift Valley fever, according to a study published online January 28 in the Proceedings of the National Academy of Sciences.

Researchers have been increasingly focused on finding antibiotics called “broad spectrum” antibiotics, which are effective against many different types of bacteria. Thus far, however, few broad spectrum antivirals have been discovered. Most available antiviral drugs tend to be effective against only one disease or a particular family of viruses.

LJ001, discovered by researchers at the University of California in Los Angeles (UCLA), the University of Texas at Galveston, Harvard University, Cornell University and the Army Medical Research Institute of Infectious Diseases, may be one such broad spectrum antiviral. Derived from an acidic chemical called rhodanine, it was uncovered by sifting through a library of more than 30,000 compounds.

LJ001 appears, thus far, to be effective against a host of viruses, including HIV, influenza A and Ebola. UCLA will patent the compound.

As the researchers were testing LJ001, they realized it was effective only against viruses with fatty membranes that interact with human cells. LJ001 also appears harmful to cell membranes, but cell membranes can repair themselves while viral membranes cannot. In turn, the researchers believe the compound could be safe for humans, while still effective at killing viruses.

Though LJ001 is nontoxic at doses that kill viruses in animals, more testing will be needed to determine whether it’s safe for humans. The researchers also haven’t yet determined exactly how the compound is able to deactivate the viral membrane.

Search: broad spectrum, antiviral, antibiotic, Ebola, Rift Valley Fever, lipid, membrane, LJ001, UCLA


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Jeton Ademaj, , 2010-02-10 10:44:46
this is a fascinating development. I'm eager to see if such an anti-viral could be additive to current ARV regimens...but i also see a darkside. in case of any widespread epidemics, such a drug would be far more valuable than gold...and anyone thought to possess it would be a target.

nee nee, new york, 2010-02-03 21:44:11
how to prevent wasting when infected with the hiv virus.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy